WHO warns new Mu variant of Covid-19 could be more vaccine-resistant

The World Health Organisation has said that it is closely monitoring a new coronavirus "variant of interest" named Mu, warning that the new variant shows signs of possible resistance to vaccines

Coronavirus mutation, coronavirus strain, coronavirus variant
Photo: Shutterstock
Press Trust of India Geneva
3 min read Last Updated : Sep 02 2021 | 2:10 PM IST

The World Health Organisation has said that it is closely monitoring a new coronavirus "variant of interest" named Mu, warning that the new variant shows signs of possible resistance to vaccines.

Mu - also known by its scientific name as B.1.621 - was first identified in Colombia in January 2021, and since then, there have been "sporadic reports" of cases and some larger outbreaks in South America and Europe, the UN health agency said in its weekly bulletin on the pandemic on Tuesday.

The cases of the Mu variant have also been reported in the UK, Europe, the US and Hong Kong.

The new 'variant of interest' is being closely monitored, the UN health agency said.

Although the global prevalence of the Mu variant among sequenced COVID-19 cases is currently below 0.1%, its prevalence in Colombia (39%) and Ecuador (13%) has consistently increased, it said.

The new variant was added to the WHO's watchlist on August 30 after it was detected in 39 countries and found to possess a "constellation of mutations that indicate potential properties of immune escape," it said.

Reports on the variant's prevalence should be "interpreted with due consideration given the low sequencing capacity of most countries, the UN agency said.

Mu is the fifth variant of interest to be monitored by the WHO since March. It has a number of mutations that suggest it could be more resistant to vaccines, the WHO warned, but said that further research would be needed to confirm this.

The preliminary data shows it may evade immune defences in a similar way to the Beta variant first discovered in South Africa, the UN agency said, adding that this needs to be confirmed by further work.

"More studies are required to understand the phenotypic and clinical characteristics of this variant, it said, adding that the epidemiology of the Mu variant in South America, particularly with the co-circulation of the Delta variant, will be monitored for changes.

As of August 29, over 4,500 sequences (3,794 B.1.621 sequences and 856 B.1.621.1 sequences), genome sequences, analysed samples of the virus taken from patients, have been designated as Mu in the past four weeks. The sequences are used to track how it moves through the population, on an open-source genome repository, known as GISAID.

Most of these have been reported in the U.S (2,065) and Colombia (852), Mexico (357) and Spain (473).

Meanwhile, South African scientists are closely monitoring the development of another new variant there.

Scientists from National Institute for Communicable Diseases (NICD) and the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) in South Africa said the potential variant of interest, C.1.2, was first detected in the country in May this year.

C.1.2 has since been found in China, the Democratic Republic of the Congo, Mauritius, England, New Zealand, Portugal and Switzerland as of August 13, they said.

However, C.1.2, is not yet a variant to follow, nor a variant of concern, according to the classification of the World Health Organization.

All viruses mutate over time and most mutations have little to no impact on the virus' behaviour.

The novel coronavirus pandemic has killed more than 45 lakh people globally, according to tracking data from Johns Hopkins University.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelta variant of coronavirusWorld Health OrganizationCoronavirus VaccineCoronavirus TestsVaccination

First Published: Sep 02 2021 | 2:10 PM IST

Next Story